News @ JSI

JSI’s work with Ebola survivors in Liberia gains recognition

January 4, 2018

In Liberia, JSI has been working to strengthen the health system and improve health services for Ebola survivors, while combating stigma and discrimination for survivors. Implemented through the USAID-funded Advancing Partners and Communities project, several recent events have been highlighted in the media.

The world is learning that one long-term aspect of Ebola virus disease (EVD) among survivors is the persistence of the virus in eye tissue causing cataracts. People with cataracts have difficulty seeing because the lens of the eye becomes cloudy. Cataracts are the leading cause of reversible blindness in the world, and surgery is the only known cure.

JSI has engaged with the Partnership for Research on Ebola Virus in Liberia (PREVAIL) to conduct a clinical research study where Ebola survivors benefit from cataract removal surgeries. In late September 2017, JSI also partnered with Samaritan’s Purse, ELWA Hospital in Liberia, and the National Institutes for Health to bring in cataract surgeons, ophthalmologists, and lab specialists from Emory and Johns Hopkins University hospitals, among others, to perform cataract surgeries for Ebola survivors in Liberia. The PREVAIL research activity was recently highlighted in various media across Africa: PREVAIL Conducts Cataract Removal Surgeries.

This work has also been featured in a USAID photo essay, A Brighter Future: After cataract surgeries, Ebola survivors in Liberia regain sight. The project was in the news last month for equipment that JSI donated to Liberian health centers to improve quality of care, particularly in facilities that serve Ebola survivors. Read more in the press.

Learn more about JSI's work in Liberia through at the Advancing Partners and Communities website.